Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma.
Liu B, Fang X, Kwong DL, Zhang Y, Verhoeft K, Gong L, Zhang B, Chen J, Yu Q, Luo J, Tang Y, Huang T, Ling F, Fu L, Yan Q, Guan XY.
Liu B, et al. Among authors: yu q.
J Exp Clin Cancer Res. 2022 May 25;41(1):182. doi: 10.1186/s13046-022-02401-6.
J Exp Clin Cancer Res. 2022.
PMID: 35610614
Free PMC article.